With a portfolio of 8 medical device companies and growing, Rainbow Medical utilizes its unique platform, network, expertise and knowhow to maximize and expedite portfolio success.
Enopace Biomedical is developing the world’s first intravascular neurostimulator, implanted percutaneously through a femoral approach. The device is designed to treat congestive heart failure patients by reducing the left ventricle workload, increasing aortic compliance and balancing the autonomic nervous system.
Maxillent developed an innovative, minimally invasive technique for dental sinus lift procedures. The device and technique reduces the need for complex surgery in approximately 25% of dental implant procedures, minimizing pain and complications.
GluSense is developing a fully implantable, injectable, long-term continuous glucose monitor (CGM) to improve the accuracy and comfort of glucose management by people with diabetes.
BlueWind Medical is developing an innovative wireless neurostimulation platform for the treatment of various clinical indications. The company’s first products are approved in Europe for treating overactive bladder (OAB) and peripheral neuropathic pain (PNP).
Nano-Retina is developing a miniature artificial retina to restore vision to people who are blind due to retinal degeneration. The advanced miniature device is implanted in a minimally invasive technique under local anesthesia and provides superior vision resolution due to its 600 proprietary electrodes and 3DNi™ technology.
Vascular Dynamics is developing an implantable stent-like device to treat resistive hypertension. The device is placed in the carotid artery via a percutaneous femoral approach procedure, and has been shown in clinical studies to significantly reduce blood pressure in patients with drug-resistant hypertension.
ChroniSense Medical develops a disease management platform that monitors vital signs, including accurate blood-pressure, as well as other health factors, allowing patients and healthcare professionals to manage chronic illnesses without interfering with the patient’s everyday activities, within or outside the home.
Slender Medical is developing an innovative skin rejuvenation home treatment using non-invasive high-intensity focused ultrasound (HIFU).
Pythagoras Medical is developing an innovative mapping system to guide renal denervation procedures, identifying appropriate denervation locations and providing immediate feedback on the success of the denervation process.
Roboscopy Medical develops an efficient, low-cost robotic system for minimally invasive surgical procedures.
Perifect is developing an innovative video-guided pericardial access device. The device makes pericardial access simpler and safer, opening the door to multiple emerging procedures, such as epicardial ablation, epicardial pacing, left-atrial appendage closure, and more.
Discure Technologies is developing a minimally invasive implant, designed to reverse the process of spinal disc degeneration, reducing pain and restoring functionality to patients, via a novel bioelectric approach.
BrainBalance is developing a novel device for the treatment of Alzheimer’s disease. The minimally invasive device is designed to enhance the natural clearance of Aβ, using a directional electrical field.